(in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | $422.03 | $405.48 | ||
Short term investments | $9.97 | |||
Net receivables | $3030.04 | $3196.97 | $3223.71 | |
Inventory | $2872.25 | $2786.8 | $2966.34 | |
Total current assets | $7033.7 | $6798.62 | $6942.56 | |
Long term investments | $1207.23 | $1150.78 | ||
Property, plant & equipment | $2839.54 | $2875.67 | $2870.92 | |
Goodwill & intangible assets | $18323.61 | $18541.26 | ||
Total noncurrent assets | $22499.22 | $22635.78 | ||
Total investments | $1207.23 | $1160.75 | ||
Total assets | $29600.83 | $29297.84 | $29578.33 | |
Current liabilities | ||||
Accounts payable | $1953.48 | $1991.64 | $1964.21 | |
Deferred revenue | ||||
Short long term debt | $3403.07 | $4080.76 | ||
Total current liabilities | $7338.03 | $7313.31 | $7994.37 | |
Long term debt | $6673.3 | $7157.03 | $7290.21 | |
Total noncurrent liabilities | $9903.64 | $9983.54 | ||
Total debt | $10560.1 | $11370.97 | ||
Total liabilities | $16708.94 | $17216.95 | $17977.91 | |
Shareholders' equity | ||||
Retained earnings | $19593.08 | $19104.6 | $18529.56 | |
Other shareholder equity | $12891.9 | -$1438.01 | -$1408.37 | |
Total shareholder equity | $12071.97 | $11590.85 |
(in millions $) | 31 Jan 2025 | 30 Jul 2023 | 30 Jul 2022 | 30 Jul 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $422.03 | $475.18 | $535.8 | $733.12 |
Short term investments | $8.39 | $27.86 | $39.12 | |
Net receivables | $3196.97 | $3136.46 | $2885.26 | $2183.59 |
Inventory | $2786.8 | $2907.88 | $2214.55 | $2090.64 |
Total current assets | $6798.62 | $6834.23 | $12046.64 | $5616.75 |
Long term investments | $1207.23 | $1104.58 | $788.06 | $774.24 |
Property, plant & equipment | $2875.67 | $2865.03 | $2122.76 | $2266.48 |
Goodwill & intangible assets | $18323.61 | $19079.21 | $10875.9 | $11579.48 |
Total noncurrent assets | $22499.22 | $23130.24 | $13897.3 | $14724.45 |
Total investments | $1207.23 | $1112.97 | $815.92 | $813.36 |
Total assets | $29297.84 | $29964.47 | $25943.94 | $20341.2 |
Current liabilities | ||||
Accounts payable | $1991.64 | $2050.93 | $1731.92 | $1667.88 |
Deferred revenue | ||||
Short long term debt | $3403.07 | $3763.18 | $1724.31 | $2.82 |
Total current liabilities | $7313.31 | $7735.37 | $5859.32 | $3096.5 |
Long term debt | $7157.03 | $8796.28 | $9755.83 | $6582.05 |
Total noncurrent liabilities | $9903.64 | $11890.82 | $11224.7 | $8831.03 |
Total debt | $10560.1 | $12559.46 | $11480.14 | $6584.88 |
Total liabilities | $17216.95 | $19637.58 | $17095.93 | $11927.53 |
Shareholders' equity | ||||
Retained earnings | $19104.6 | $17041.5 | $15661.81 | $14915.5 |
Other shareholder equity | -$1438.01 | $10326.89 | $8848.01 | $8413.67 |
Total shareholder equity | $12071.97 | $10326.89 | $8848.01 | $8398.31 |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $4903.98 | $5074.36 | $4820.95 | |
Cost of revenue | $3279.65 | $3101.96 | ||
Gross Profit | $1806.27 | $1794.71 | $1718.98 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $816.34 | $806.8 | ||
Total operating expenses | $848.79 | $816.34 | $806.8 | |
Operating income | $978.37 | $912.18 | ||
Income from continuing operations | ||||
EBIT | $1043.62 | $996.99 | ||
Income tax expense | $176.66 | $193.31 | $186.11 | |
Interest expense | -$113.09 | $123.73 | $129.03 | |
Net income | ||||
Net income | $698.42 | $726.57 | $681.85 | |
Income (for common shares) | $726.57 | $681.85 |
(in millions $) | 31 Dec 2024 | 30 Jul 2023 | 30 Jul 2022 | 31 Jan 2022 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $19929.61 | $19065.19 | $15861.61 | $14347.64 |
Cost of revenue | $12801.82 | $10449.68 | ||
Gross Profit | $7127.79 | $6429.3 | $4474.34 | $3897.96 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $3315.18 | $1527.3 | ||
Total operating expenses | $3315.18 | $3354.1 | $1627.12 | $1527.98 |
Operating income | $3812.61 | $2370.66 | ||
Income from continuing operations | ||||
EBIT | $4100.38 | $2496.23 | ||
Income tax expense | $749.67 | $596.13 | $298.04 | $500.1 |
Interest expense | $506.5 | -$573.89 | -$255.25 | $250.04 |
Net income | ||||
Net income | $2844.22 | $2082.94 | $1315.61 | $1746.1 |
Income (for common shares) | $2844.22 | $1746.1 |
(in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
---|---|---|---|---|
Net income | $784.96 | $726.57 | $681.85 | |
Operating activities | ||||
Depreciation | $230.67 | $228.3 | $227.78 | |
Business acquisitions & disposals | $2.1 | $0.97 | $37.9 | |
Stock-based compensation | $26.49 | $20.62 | $30.17 | |
Total cash flows from operations | $1237.25 | $795.09 | $702.03 | |
Investing activities | ||||
Capital expenditures | -$116.62 | -$71.67 | -$105.72 | |
Investments | $8.53 | $1.09 | -$2.07 | |
Total cash flows from investing | -$86.61 | -$104.29 | -$63.19 | -$75.12 |
Financing activities | ||||
Dividends paid | -$209.94 | -$210.47 | -$190.47 | -$190.69 |
Sale and purchase of stock | -$90.76 | -$101.3 | -$58.25 | |
Net borrowings | -$808.15 | -$408.53 | -$438.44 | |
Total cash flows from financing | -$710.96 | -$1109.37 | -$700.29 | -$687.38 |
Effect of exchange rate | $2.63 | -$7.05 | -$8.95 | -$5.64 |
Change in cash and equivalents | -$50.96 | $16.54 | $22.67 | -$66.11 |
(in millions $) | 31 Dec 2024 | 30 Jul 2023 | 30 Jul 2022 | 30 Jul 2021 |
---|---|---|---|---|
Net income | $2844.22 | $1746.86 | ||
Operating activities | ||||
Depreciation | $927.13 | $595.39 | ||
Business acquisitions & disposals | $77.67 | |||
Stock-based compensation | $155.18 | $121.48 | ||
Total cash flows from operations | $3384.33 | $2575 | ||
Investing activities | ||||
Capital expenditures | -$391.05 | -$69.37 | ||
Investments | $7.11 | $44.61 | ||
Total cash flows from investing | -$298.59 | -$8176.81 | -$418.84 | -$0.01 |
Financing activities | ||||
Dividends paid | -$782.05 | -$704.05 | -$569.86 | -$475.17 |
Sale and purchase of stock | -$328.45 | -$214.13 | ||
Net borrowings | -$2001.52 | -$1934.03 | ||
Total cash flows from financing | -$3114.9 | -$971.04 | $3915.64 | -$2623.34 |
Effect of exchange rate | -$24 | -$4.78 | -$23.77 | $95.95 |
Change in cash and equivalents | -$53.16 | -$6172.69 | $5914.76 | $47.6 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | 1.43 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |